biostudies-literatureUnknown8(3)Fu L<b><i>Background and Aims:</i></b> Coronavirus disease 2019 (COVID-19) is a new respiratory infectious disease caused by severe acute respiratory syndrome coronavirus-2 (commonly known as SARS-CoV-2) with multiple organ injuries. The aim of this study was to analyze COVID-19-associated liver dysfunction (LD), its association with the risk of death and prognosis after discharge. <b><i>Methods:</i></b> Three-hundred and fifty-five COVID-19 patients were recruited. Clinical data were collected from electronic medical records. LD was evaluated and its prognosis was tracked. The association between LD and the risk of death was analyzed. <b><i>Results:</i></b> Of the 355 COVID-19 patients, 211 had mild disease, 88 had severe disease, and 51 had critically ill disease. On admission, 223 (62.8%) pJournal of clinical and translational hepatology246-254https://www.ebi.ac.uk/biostudies/studies/S-EPMC7562804biostudies-literatureLiver Dysfunction and Its Association with the Risk of Death in COVID-19 Patients: A Prospective Cohort Study.PMC7562804Li YLi MDLiu FFXu SXiang YFu LXu DXLi XYFei JHu BXiang HXZhao HfalseLiver Dysfunction and Its Association with the Risk of Death in COVID-19 Patients: A Prospective Cohort Study.<b><i>Background and Aims:</i></b> Coronavirus disease 2019 (COVID-19) is a new respiratory infectious disease caused by severe acute respiratory syndrome coronavirus-2 (commonly known as SARS-CoV-2) with multiple organ injuries. The aim of this study was to analyze COVID-19-associated liver dysfunction (LD), its association with the risk of death and prognosis after discharge. <b><i>Methods:</i></b> Three-hundred and fifty-five COVID-19 patients were recruited. Clinical data were collected from electronic medical records. LD was evaluated and its prognosis was tracked. The association between LD and the risk of death was analyzed. <b><i>Results:</i></b> Of the 355 COVID-19 patients, 211 had mild disease, 88 had severe disease, and 51 had critically ill disease. On admission, 223 (62.8%) p2020-01-01T00:00:00Z2020 Sep2025-04-19T03:20:28.064Z2020-10-29T12:37:22ZS-EPMC75628043308324610.14218/JCTH.2020.00043